Vertex Pharmaceuticals (VRTX) FCF Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -5,426.00 |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 9,545.00 |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 4,612.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -3,088.00 |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 14,060.00 |
| 10 | Incyte | 25.64 Bn | 21.11 Bn | 1.57 Bn | -176.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,272.00 |
| Mar 31, 2026 | 723.00 |
| Dec 31, 2025 | -3,444.00 |
| Sep 30, 2025 | -157.00 |
| Jun 30, 2025 | -1,819.00 |
| Mar 31, 2025 | -1,446.00 |
| Dec 31, 2024 | -2,813.00 |
| Sep 30, 2024 | 288.00 |
| Jun 30, 2024 | -13,057.00 |
| Mar 31, 2024 | -328.00 |
| Dec 31, 2023 | -2,026.00 |
| Sep 30, 2023 | 179.00 |
| Jun 30, 2023 | -2,384.00 |
| Mar 31, 2023 | -1,643.00 |
| Dec 31, 2022 | 1,500.00 |
| Sep 30, 2022 | 592.00 |
| Jun 30, 2022 | 194.00 |
| Mar 31, 2022 | 682.00 |
| Dec 31, 2021 | 1,067.00 |
| Sep 30, 2021 | -185.00 |